Definition · Healthtech & Telehealth

Razorpay for Healthtech & Telehealth

Razorpay (Payment Gateway) — applied to Healthtech & Telehealth. Trust-led acquisition with DPDP/clinical compliance built in.

  1. Razorpay = India's leading payment gateway.

  2. Fee: 2% cards / 0.5% UPI + GST.

  3. Healthtech & Telehealth band: CPC 20–200 ₹ · CAC 500–7,500 ₹.

Definition

Razorpay is India's leading payment gateway, supporting cards, UPI, netbanking, wallets, BNPL, COD, and EMI. Razorpay is dominant in Indian D2C (40–60% market share). Standard fees: 2% for cards, ~0.5% for UPI. Setup is fast; integration with Shopify, WooCommerce, custom carts is well-supported. For Healthtech & Telehealth specifically, this metric sits inside the unit-economics envelope of CPC 20–200 ₹ and CAC 500–7,500 ₹, constrained by DPDP compliance and physician outreach.

Formula

Razorpay is an Indian payment gateway processing card, UPI, netbanking, wallet, BNPL, COD, and EMI transactions for online businesses.

Razorpay Fee = ~2% (cards) + ~0.5% (UPI) + GST

India Razorpay benchmarks

Common Razorpay mistakes (Healthtech edition)

Context

How Razorpay actually behaves in healthtech & telehealth

Razorpay is the default choice for Indian D2C in 2026. Setup takes 1–3 days post-KYC. Beyond payments, Razorpay offers: Razorpay Capital (working capital loans), Razorpay X (business banking), Magic Checkout (one-click checkout), Smart Routing (best-cost gateway selection). Compare to Cashfree (similar fees, slightly more developer-friendly) and PayU (more enterprise-focused). For most Indian D2C, Razorpay is the right default.

For healthtech & telehealth specifically, Razorpay is influenced most by these 5 primary channels — each shifts the metric in a different way: SEO Services (compounding organic growth — pillar/cluster, programmatic, and ai-engine-cited.); Google Ads (search, shopping, youtube, and performance max — engineered for indian unit econ); Content Marketing (editorial + programmatic — built to be cited by ai engines.); Meta Ads (facebook + instagram + whatsapp — built for d2c, real-estate, and lead-gen.).

Channel adaptations

How Razorpay moves per primary channel for healthtech & telehealth

30-min audit

Want this Razorpay review scoped to your Healthtech business?

30 minutes, no slides. We'll examine your razorpay setup against Healthtech-specific benchmarks and tell you the highest-leverage move to make first.

FAQ

Frequently asked questions

What's a typical Razorpay for Healthtech & Telehealth?

Healthtech & Telehealth Razorpay runs in the band 20–200 ₹ CPC / 500–7,500 ₹ CAC. Wider India benchmarks: Razorpay market share India D2C: 40–60%; Standard fees: 2% (cards), 0.5% (UPI), 1.95% (netbanking). Healthtech-specific drivers: DPDP compliance, physician outreach.

How does Healthtech change how you optimize Razorpay?

Healthtech businesses optimize Razorpay via seo-services, google-ads, content-marketing primarily. The category's unit economics — average CAC 500–7,500 ₹, repeat-purchase dynamics, and DPDP compliance — constrain which levers move Razorpay fastest. Generic Razorpay advice ignores these constraints.

Which Healthtech Razorpay mistakes does Frameleads see most?

Across Healthtech & Telehealth engagements, the top recurring mistakes are: Not negotiating fee at scale (custom rates from ₹50L/month volume).; Not enabling UPI to reduce fees.; and treating Razorpay as an isolated number rather than connecting it to UPI and COD.

What's the fastest way to improve Razorpay for a Healthtech business?

Three levers move Razorpay for Healthtech: (1) tighter ICP definition so paid spend hits the right audience; (2) creative supply pipelines tuned to Healthtech-specific buyer norms; (3) retention plumbing so each acquired customer compounds the metric. The 30-min audit identifies which of these three is the bottleneck in your specific funnel.

Deeper reading

Long-form guides on related topics

Related terms

Pair this with

Linked content

More Healthtech & Telehealth metrics & definitions

Linked content

Razorpay for other industries

Sources & references

Cited primary and analyst sources. Independent of Frameleads' own data.

  1. DPDP Act 2023 — Digital Personal Data ProtectionMinistry of Electronics & IT, Government of India

    Patient data, consent flows, and lead handling for healthcare and healthtech.

  2. NMC — National Medical Commission: code of medical ethics & advertisingNMC

    Doctor and clinic advertising rules; testimonial and claim substantiation.

  3. IBEF — India Brand Equity Foundation: Indian Industry ReportsIBEF (Ministry of Commerce & Industry)

    Sector-level market size, growth, and policy context for Indian industries.

  4. IAMAI — Internet & Mobile Association of IndiaIAMAI

    Digital advertising industry body; reports on India internet user base, ad spend, and platform shares.

  5. MoSPI — Ministry of Statistics and Programme ImplementationGovernment of India

    Primary source for India macro-economic indicators (CPI, GDP, household consumption).

  6. ASCI Code for Self-Regulation of Advertising in IndiaAdvertising Standards Council of India

    Mandatory baseline for all advertising claims in India — including digital, influencer, and comparative ads.

Last reviewed: by Frameleads Editorial TeamRefreshed quarterly from live client data